-
Novel pathogenic variants in CTLA4 and LRBA immune dysregulation: Reduced CTLA-4 expression with normal expression of co-stimulatory surface molecules
Tromp, S. A. M., van Leeuwen, E. M. M., Jansen, M. H., Kwakernaak, A. J., Bomers, M. K., Jonkers, R. E., van Spaendonk, R. M. L., Kuijpers, T. W. & de Bree, G. J., 1 Nov 2025, In: Clinical Immunology. 280, 110565.Research output: Contribution to journal › Article* › Academic › peer-review
-
Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19 (Genome Medicine, (2023), 15, 1, (22), 10.1186/s13073-023-01173-8)
COVID Human Genetic Effort, COVIDeF Study Group, French COVID Cohort Study Group, CoV-Contact Cohort, COVID-STORM Clinicians, COVID Clinicians, Orchestra Working Group, Amsterdam UMC Covid-19 Biobank & NIAID-USUHS COVID Study Group, Dec 2024, In: Genome medicine. 16, 1, p. 6 1 p., 6.Research output: Contribution to journal › Comment/Letter to the editor* › Academic
-
The effect of immunosuppressive therapies on the endothelial host response in critically ill COVID-19 patients
Amsterdam UMC COVID-19 biobank study group, the Amsterdam UMC COVID-19 biobank study group & The Radboudumc Center for Infectious Diseases COVID-19 Study Group, Dec 2024, In: Scientific reports. 14, 1, p. 9113 1 p., 9113.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
